U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 31 - 40 of 93

Non-prescription ('Over-the-Counter') Naloxone Frequently Asked Questions

The following questions and answers provide details about purchasing and using Narcan 4mg naloxone hydrochloride nasal spray specifically, health plan coverage, training resources, other formulations of naloxone available, and federal grant funding aimed toward increasing access to naloxone in communities across the country.

Format
Web Page
Audience
Communities
Families
Patients
Schools
Source
Substance Abuse and Mental Health Services Administration (SAMHSA)
Year
Resource Type
Web Page

Opioid-Overdose Reduction Continuum of Care Approach (ORCCA) Practice Guide

This guide includes (1) a menu of evidence-based practices spanning the continuum of care to reduce opioid overdose deaths and (2) real-word tips for implementing the evidence-based strategies.
Format
Guide
Audience
Communities
Other Team Members
States
Source
National Institutes of Health (NIH)
Year
Resource Type
PDF
File Size
10.4 MB

Pain in the Nation 2023: The Epidemics of Alcohol, Drug, and Suicide Deaths

These recommendations from TFAH, primarily aimed at federal and state governments, aim to reduce alcohol, drug, and suicide deaths and to improve mental health and well-being for all Americans.
Format
Report/Paper/Issue Brief
Audience
States
Policymakers and Payers
Source
Trust for America's Mental Health (TFAH)
Year
Resource Type
PDF
File Size
1.7 MB

Wounds, Withdrawal, and Overdose: What to Expect from Xylazine Drug Supply Adulteration

This 75-minute on-demand session from the ASAM 54th Annual Conference addresses the pharmacology, toxicology, diagnostic testing, and epidemiology of xylazine in exposures. The session includes didactic content, case-based narrative, review of literature, and panel discussion to review important topics about the emerging xylazine crisis in the US.
Format
Web-Based Course
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
American Society of Addiction Medicine (ASAM)
Year
Resource Type
Video

Fentanyl Drug Checking and Screening: Roundtable on Clinical Perspectives Summary Report

This document summarizes the discussion from the meeting of clinicians and researchers who are knowledgeable about screening for fentanyl and other drugs, primarily in health care settings. The focus of the meeting was to understand clinician/researcher perspectives about clinical fentanyl testing and distribution of fentanyl test strips (FTS) to patients and discuss next steps for technology development, research, and practice.
Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Reagan-Udall Foundation for the FDA (Food and Drug Administration)
Year
Resource Type
PDF
File Size
562 KB